Esperion Therapeutics
ESPR
ESPR
50 hedge funds and large institutions have $136M invested in Esperion Therapeutics in 2014 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 15
Holders
50
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.69M | |
| 2 | +$2.03M | |
| 3 | +$1.69M | |
| 4 |
Jane Street
New York
|
+$1M |
| 5 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
+$734K |
Top Sellers
| 1 | -$5.16M | |
| 2 | -$489K | |
| 3 | -$353K | |
| 4 |
SIM
SSI Investment Management
Los Angeles,
California
|
-$283K |
| 5 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$245K |